Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas
Autor: | Jomol Cyriac, Leon M. Novak, Francis Nugent, Maroun Karam, Ameera Ali, Tipu Nazeer |
---|---|
Rok vydání: | 2006 |
Předmět: |
Cancer Research
Lymphoma B-Cell Follicular lymphoma Sensitivity and Specificity Fluorodeoxyglucose F18 hemic and lymphatic diseases medicine Humans Lymphoma Follicular Neoplasm Staging Retrospective Studies medicine.diagnostic_test business.industry Lymphoma Non-Hodgkin Deoxyglucose Cancer Histology Retrospective cohort study medicine.disease Leukemia Lymphocytic Chronic B-Cell Lymphoma Leukemia Oncology Positron emission tomography Positron-Emission Tomography business Nuclear medicine |
Zdroj: | Cancer. 107:175-183 |
ISSN: | 1097-0142 0008-543X |
Popis: | BACKGROUND Fluorine-18 fluoro-deoxyglucose positron emission tomography (FDG-PET) scanning has excellent sensitivity and specificity for staging non-Hodgkin lymphomas, but to the authors' knowledge few studies to date have evaluated FDG-PET in low-grade lymphomas only. METHODS A retrospective study was performed on patients with biopsy-proven nontransformed and transformed follicular lymphoma (FL), B-cell small-cell lymphocytic lymphoma (SLL/CLL), or marginal zone lymphoma (MZL) who underwent PET and computed tomography (CT) scans within 3 weeks. Standard uptake values (SUV) of all abnormal foci were measured. RESULTS In FL, PET demonstrated 94% sensitivity and 100% specificity for staging. PET was more specific than CT for detecting recurrence or assessing therapeutic responses (91% vs. 50%). FDG avidity among patients with WHO Grades 1, 2, and 3 disease was not significantly different (analysis of variance [ANOVA]). For MZL staging, PET had moderate sensitivity (71%) and outperformed CT alone in the depiction of extranodal sites (85% vs. 57% sensitivity). In SLL/CLL, PET sensitivity was 53% and underestimated disease extent in 5 of 19 patients (26%) compared with CT. PET did not affect initial management but confirmed suspected recurrences in 75% of patients. Nontransformed FL had a higher SUV (ANOVA, P |
Databáze: | OpenAIRE |
Externí odkaz: |